20 March 2025: Articles
Bilateral Papilledema in a Child with Spinal Myxopapillary Ependymoma: A Case Report
Unusual clinical course, Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Qi-Yuan Song1ABDEF, Kui Lv1B, Tian-Yi Luo2CDEF, Wei-Guo Cao1CDE, Hui Zhong3AG*DOI: 10.12659/AJCR.946269
Am J Case Rep 2025; 26:e946269
Abstract
BACKGROUND: Myxopapillary ependymomas, a subtype of spinal ependymomas, are relatively rare in children and adolescents, primarily affecting the lower spinal region; however, they can also metastasize along the spinal axis, as well as intracranially. The clinical presentation typically involves signs and symptoms of conus medullaris or cauda equina dysfunction, including paralysis and sensory loss, accompanied by lower back pain. Ocular complications are not commonly seen in myxopapillary ependymomas. This case report emphasizes the need to consider spinal tumors in patients presenting with bilateral papilledema, particularly in the presence of neurological symptoms or increased cerebrospinal fluid protein levels. It also stresses the importance of spinal MRI to prevent misdiagnosis during ophthalmic assessments.
CASE REPORT: A 12-year-old boy, previously diagnosed with neuromyelitis optica at another hospital and initially responsive to intravenous methylprednisolone, returned with relapsed vision loss and neck and back pain. At Shenzhen Children’s Hospital, an ophthalmological examination showed bilateral papilledema with poorly defined margins. Due to his neurological symptoms, a consultation was conducted, revealing several positive signs. A lumbar puncture indicated elevated cerebrospinal fluid pressure and protein levels. A subsequent spinal MRI identified a space-occupying lesion in the spinal column. The patient underwent neurosurgical intervention to remove the intradural lesion, and the pathology confirmed a WHO Grade 2 myxopapillary ependymoma. Postoperatively, his right eye vision improved to 20/40, and his left eye vision to 20/20, resolving his diplopia and restoring normal muscle strength and tone in all limbs. However, a tumor recurrence 3 months later necessitated a second surgery.
CONCLUSIONS: Ocular complications are rare in pediatric patients with myxopapillary ependymoma. Timely recognition of associated symptoms by ophthalmologists, followed by a comprehensive neurological evaluation to uncover potential neurologic issues, can significantly improve outcomes through early intervention for myxopapillary ependymoma.
Keywords: ependymoma, papilledema, Diagnosis
Introduction
Spinal ependymomas are central nervous system tumors that arise from the ependymal cells lining the central canal of the spinal cord. These tumors are typically graded on a fourtier scale, ranging from low-grade malignancy (WHO Grade 1) to high-grade malignancy (WHO Grade 4) [1]. They can occur along any segment of the spinal cord but are most frequently found in the thoracic region. The symptoms associated with spinal ependymomas are generally related to the location and size of the tumor and may include back pain, muscle weakness, sensory abnormalities, gait disturbances, and dysfunction of the bladder or bowels [2–4]. Myxopapillary ependymoma, a subtype of spinal ependymoma, predominantly occurs in the conus medullaris and cauda equina regions of adults [5], and is relatively rare in the pediatric and adolescent population [6,7]. Literature also reports that myxopapillary ependymoma can metastasize along the spinal axis as well as intracranially [8]. Hence, prior to neurosurgical intervention, MRI examination of the brain and the entire spinal cord is highly recommended. Clinical presentations of myxopapillary ependymoma commonly include signs and symptoms of spinal cord or cauda equina dysfunction (paralysis, sensory loss), along with lower back pain [9]. Ocular complications, such as bilateral papilledema, visual impairment, and diplopia, are less frequently observed in myxopapillary ependymoma patients [10]. These cases often face misdiagnosis and delayed treatment due to the primary lesion being overlooked during initial ophthalmologic assessments. The case we report here initially presented to ophthalmology due to bilateral papilledema, with symptom recurrence despite steroid therapy. Fortunately, thorough neurological examinations, including lumbar puncture and imaging studies, revealed the patient’s primary myxopapillary ependymoma, facilitating the necessary surgical intervention.
Case Report
A 12-year-old boy presenting with decreased visual acuity, neck, and back pain was previously diagnosed with optic neuromyelitis at another hospital. He received treatment with intravenous methylprednisolone and was discharged upon improvement of his visual symptoms. However, experiencing a deterioration in visual acuity and neck pain, he sought further medical attention at Shenzhen Children’s Hospital shortly after his discharge. The ophthalmological examination revealed that the right eye had a visual acuity of 20/60, while the left eye had a visual acuity of 20/25. Both pupils exhibited sluggish direct light reflexes. The optic papillae in both eyes showed congested hemorrhages with unclear borders, and a retinitis pigmentation disorder in the macular area (Figure 1A, 1B). Optical coherence tomography (OCT) displayed bilateral papilledema, superficial detachment of the nerve fiber layer from the pigment epithelium in the macular region of both eyes, and subretinal fluid (Figure 1C, 1D). Visual Evoked Potentials (VEP) indicated prolonged P100 latency and decreased amplitude in both eyes. Cerebrospinal fluid antibodies were negative. The clinical diagnosis was bilateral papilledema with further etiological investigation required, leading to a referral to neurology. The neurological examination revealed various abnormalities including neck tonus, bilateral vertical nystagmus, reduced muscle strength in the distal right lower limb, nociceptive hypersensitivity in the right lower limb, absence of abdominal reflexes, unelicited knee jerks and Achilles tendon reflexes, a positive right Babinski sign, as well as positive Kerning and Brudzinski signs. Lumbar puncture measured the cerebrospinal fluid pressure at 240 mmH2O (normal range: 80–180 mmH2O), indicating increased intracranial pressure. Analysis of the cerebrospinal fluid showed protein of 157 mg/dL (normal <50 mg/dL). Cranial, orbital, full-spine MRI, and contrast-enhanced lumbar spine MRI revealed bilateral optic nerve edema (Figure 2A, 2B), spinal cord flattening, likely due to elevated intracranial pressure, no hydrocephalus was detected (Figure 2A), and an intradural lesion in the lumbar region, likely neoplastic in nature (Figure 2C–2E). The patient was referred to the neurosurgery department for further intervention, undergoing surgical re-section of the intradural lesion (Figure 3A, 3B). The pathology report identified the tumor as myxopapillary ependymoma WHO Grade 2 (Figure 3C). Upon discharge, the child’s right eye vision improved to 20/40, left eye vision to 20/20, with reported visual field enhancement and alleviation of diplopia symptoms, alongside restoration of normal muscle strength and tone in all limbs. Three months after surgery, a follow-up spinal MRI revealed a lesion in the sacral spine, indicating tumor recurrence (Figure 4A, 4B). Subsequently, the child underwent a second resection of the spinal lesion, with the pathological diagnosis remaining as myxopapillary ependymoma (Figure 4C). After the second surgery, the patient did not follow up with the neurology or ophthalmology department as requested, and we lost contact for further follow-up.
Discussion
When bilateral papilledema is observed in a patient, the initial consideration typically focuses on the presence of intracranial lesions, while the possibility of intradural lesions may be overlooked [11]. Myxopapillary ependymomas causing bilateral optic disc swelling may stem from cerebrospinal fluid secretion disturbances and dynamics subjugation. Tumor active secretion, breakdown products, and subarachnoid hemorrhage may incite the meninges, elevating cerebrospinal fluid protein concentration [12]. Excessive protein secretion and mechanical obstruction by spinal cord tumors impede cerebrospinal fluid flow, heightening fluid viscosity that can directly affect axoplasmatic flow, leading to disc edema. Concurrently, reduced cerebrospinal fluid absorption due to subarachnoid adhesions raises intracranial pressure, exacerbating optic disc swelling [13]. Additionally, the lumbosacral region is vital for cerebrospinal fluid storage, aiding in maintaining stable intracranial pressure alongside cerebral ventricles. Mechanical obstruction by spinal tumors can diminish the “reservoir” capacity, decrease spinal compliance, and lower overall cerebrospinal fluid space compliance. When this surpasses compensatory capacity of intracranial vessels, intracranial pressure elevation occurs, precipitating optic disc swelling [11,14]. When myxopapillary ependymomas present ocular complications, the most common symptoms include decreased visual acuity, visual field defects or enlarged blind spots, transient visual confusion, and either esotropia or exotropia nerve paralysis [10]. Additional symptoms encompassed diplopia, metamorphopsia, decreased contrast sensitivity, relative afferent pupillary defect, and retrobulbar pain. These cases shared common features such as neurological signs or symptoms of myelopathy and elevated cerebrospinal fluid protein levels [11]. This underscores the importance of considering spinal imaging in patients presenting with bilateral papilledema and myelopathy-like symptoms, emphasizing the need for timely multidisciplinary consultation to develop an appropriate treatment strategy.
Due to incomplete surgical resections, large tumor volumes, and multifocal lesions, the probability of myxopapillary ependymoma recurrence or local metastasis is approximately 20%, with metastasis capable of occurring anywhere along the spinal axis, including the brain [8,15–17]. Furthermore, studies indicate that pediatric myxopapillary ependymomas are more prone to dissemination and lymphatic spread, with recurrence risks in children reaching up to 40% [18,19]. Although no multifocal metastases were detected in this case, preoperative MRI of the brain and entire spinal cord is essential for devising the surgical plan.
Conclusions
Surgical intervention remains the primary approach for definitively treating myxopapillary ependymomas [20–22]. As ophthalmologists, encountering pediatric or adolescent patients with symptoms such as visual impairment, diplopia, headache, neck or back pain, and lower back pain should prompt consideration of accompanying myxopapillary ependymomas. Promptly conducting comprehensive MRI of the brain and entire spinal cord or seeking neurology consultation can not only enhance the prognosis of ependymoma patients but also aid in identifying potential concurrent neurological disorders or tumors.
Figures
References:
1.. Gritsch S, Batchelor TT, Gonzalez CL, Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system: Cancer, 2022; 128; 47-58
2.. Marchesini N, Soda C, Ricci UM, Giant intradural extramedullary spinal ependymoma, a rare arachnoiditis-mimicking condition: Case report and literature review: Brit J Neurosurg, 2023; 37; 763-68
3.. Kumaria A, Chan HW, Goldspring RJ, Isolated myxopapillary ependymoma of the fourth ventricle: Case report and review of literature: Brit J Neurosurg, 2022; 36; 284-85
4.. Makino Y, Kawanabe Y, Fujimoto M, A case of spinal ependymoma developed in the extramedullary location: A case report and literature review: NMC Case Rep J, 2021; 8; 601-8
5.. Pajtler KW, Witt H, Sill M, Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups: Cancer Cell, 2015; 27; 728-43
6.. Peris-Bonet R, Martinez-Garcia C, Lacour B, Childhood central nervous system tumours – incidence and survival in Europe (1978–1997): Report from Automated Childhood Cancer Information System project: Eur J Cancer, 2006; 42; 2064-80
7.. Benesch M, Frappaz D, Massimino M, Spinal cord ependymomas in children and adolescents: Child Nerv Syst, 2012; 28; 2017-28
8.. Balodis A, Nevercika V, Zavertjajeva M, Giant myxopapillary ependymoma with multi-site neural axis metastases: A rare case with suboptimal outcome: Am J Case Rep, 2024; 25; e942392
9.. Lundar T, Due-Tonnessen BJ, Fric R, Outcome after treatment of spinal ependymoma in children and adolescents: long-term follow-up of a single consecutive institutional series of 33 patients treated over eight decades: World Neurosurg, 2021; 150; e228-35
10.. Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S, An update on the CNS manifestations of neurofibromatosis type 2: Acta Neuropathol, 2020; 139; 643-65
11.. Zhou Y, Mcclelland CM, Lee MS, Increased intracranial pressure without hydrocephalus associated with spinal cord tumor: Literature review: J Neuro-Ophthalmol, 2021; 41; 13-18
12.. Mirone G, Cinalli G, Spennato P, Hydrocephalus and spinal cord tumors: A review: Child Nerv Syst, 2011; 27; 1741-49
13.. Marzban AN, Saxena A, Bhattacharyya D, Ivanov M, Hydrocephalus and papilledema in spinal cord tumors: A report of two cases: Surg J (NY), 2016; 2; e51-e58
14.. Morandi X, Amlashi SF, Riffaud L, A dynamic theory for hydrocephalus revealing benign intraspinal tumours: tumoural obstruction of the spinal subarachnoid space reduces total CSF compartment compliance: Med Hypotheses, 2006; 67; 79-81
15.. Montero AS, Tran S, Amelot A, Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: A French cohort of 101 patients: J Neuro-Oncol, 2021; 152; 491-99
16.. Zhao F, Wu T, Wang LM, Survival and prognostic factors of adult intracranial ependymoma: A single-institutional analysis of 236 patients: Am J Surg Pathol, 2021; 45; 979-87
17.. Almatrafi FR, Aseeri AM, Alqahtani MF, Myxopapillary ependymoma – a case report of rare multicentric subtype and literature review: Med Arch, 2023; 77; 150-54
18.. Feldman WB, Clark AJ, Safaee M, Tumor control after surgery for spinal myxopapillary ependymomas: Distinct outcomes in adults versus children: A systematic review: J Neurosurg-Spine, 2013; 19; 471-76
19.. Liu T, Yang C, Deng X, Clinical characteristics and surgical outcomes of spinal myxopapillary ependymomas: Neurosurg Rev, 2020; 43; 1351-56
20.. Pica A, Miller R, Villa S, The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: A retrospective study from the rare cancer network: Int J Radiat Oncol, 2009; 74; 1114-20
21.. Tsai CJ, Wang Y, Allen PK, Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: Update of the MD Anderson Cancer Center experience: Neurosurgery, 2014; 75; 205-14
22.. Agbahiwe HC, Wharam M, Batra S, Management of pediatric myxopapillary ependymoma: The role of adjuvant radiation: Int J Radiat Oncol, 2013; 85; 421-27
Figures
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947953
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946932
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947854
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945927
Most Viewed Current Articles
21 Jun 2024 : Case report
96,778
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,393
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,818
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,483
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030